Evidence-Based Validation: The Rise of TCM Regulatory Science
In 2026, the skepticism surrounding traditional therapies is being addressed through Traditional Chinese Medicine Regulatory Science (TCMRS). This emerging discipline uses modern scientific tools to prove the "benefit-risk" profiles of complex herbal compounds.
Systems Biology and Network Pharmacology: Instead of the "one drug, one target" model, 2026 researchers use AI to map how a multi-herb formula (like Xuebijing) interacts with dozens of biological pathways simultaneously. This is particularly effective for treating systemic inflammation and respiratory diseases.
Pragmatic Clinical Trials: To respect the individualized nature of TCM, researchers have moved toward "Real-World Evidence" trials. These studies track thousands of patients in their daily lives to see how personalized TCM "syndromes" respond to treatment, providing a more accurate reflection of efficacy than rigid laboratory settings.